SCHEMBL5844667

SCHEMBL5844667

Cc1ccc(C(N)C(C(=O)O)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 5/20 0.37
LMNA P02545 3/20 0.36
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
SLC7A5 Q01650 1/20 0.35
ALOX5 P09917 1/20 0.35
KMT2A Q03164 1/20 0.34
XBP1 P17861 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
AKR1C3 P42330 1/20 0.33
AKR1C2 P52895 1/20 0.33
SLC1A3 P43003 1/20 0.33
SLC1A2 P43004 1/20 0.33
SLC1A1 P43005 1/20 0.33
APP P05067 1/20 0.33
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
GPR119 Q8TDV5 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2844018 0.88 SLC7A5 (0.37) KIF11LMNASLC7A5KMT2ATDP1
SCHEMBL27665873 0.87 DPP4 (0.42) SLC7A5KMT2AALDH1A1SMN1; SMN2
SCHEMBL27564999 0.87 DPP4 (0.42) SLC7A5KMT2AALDH1A1SMN1; SMN2
SCHEMBL4937584 0.87 DPP4 (0.42) SLC7A5KMT2AALDH1A1SMN1; SMN2
SCHEMBL25220978 0.86 SMN1; SMN2 (0.38) KIF11LMNASLC7A5ALOX5KMT2A
SCHEMBL1147857 0.86 APP (0.38) KIF11LMNASLC7A5KMT2AAPP
SCHEMBL390626 0.86 CYP3A4 (0.43) LMNAPPARGPPARAKMT2AAPP
SCHEMBL1147794 0.86 CYP3A4 (0.43) LMNAPPARGPPARAKMT2AAPP
SCHEMBL27514296 0.86 CYP3A4 (0.43) LMNAPPARGPPARAKMT2AAPP
SCHEMBL27655987 0.86 PDPK1 (0.36) KIF11LMNASLC7A5KMT2AAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7132539-B2 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY (US) 2006-11-07 US disclosed
US-20060247224-A1 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY 2006-11-02 US disclosed
US-20050010031-A1 Melanocortin receptor ligands THE PROCTER & GAMBLE COMPANY 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050010031-A1 Melanocortin receptor ligands MC3R, MC5R, MC1R KIF11 3271/4885LMNA 2901/4885PPARG 2593/4885
US-20060247224-A1 Melanocortin receptor ligands MC3R, MC5R, MC1R KIF11 3181/4885LMNA 2851/4885PPARG 2188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.